Professor, Medicine, University of Florida College of Medicine
Hematology
Dr. Jan S. Moreb, MD
|
|
Give Review
Doctor Jan S. Moreb, MD practices Hematology. He studied medicine at The Hebrew University of Jerusalem Hadassah Medical School. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Moreb is a published MD. He has 101 publications published. The most current publication "The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery, and cost." Moreb accepts Medicare payments and is listed with Medicare.gov.
Publications
- Ex vivo virotherapy With myxoma virus does not impair hematopoietic stem and progenitor cells.
- Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
- New cancers after autotransplantations for multiple Myeloma.
- Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development?
- Oral squamous Cell carcinoma positive for p16/human papilloma virus in post allogeneic stem Cell transplantation: 2 cases and review of the literature.
- Continuous infusion cyclophosphamide and low-dose total body irradiation is a safe and effective conditioning regimen for autologous transplant in multiple Myeloma.
- Outcomes of salvage autologous versus allogeneic hematopoietic Cell transplantation for relapsed multiple myeloma after initial autologous hematopoietic Cell transplan...
- Salvage Second Hematopoietic Cell Transplantation in Myeloma.
- Extramedullary Disease in plasma cell myeloma: the iceberg phenomenon.
- Virus-derived anti-inflammatory proteins: potential therapeutics for cancer.
- Selective purging of human multiple myeloma Cells from autologous stem Cell transplant grafts using oncolytic myxoma virus.
- Severe Neutropenia Following a Prolonged Course of Vancomycin That Progressed to Agranulocytosis With Drug Reexposure (January).
- The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significa...
- Long-Term Outcome after Autologous Stem Cell Transplantation With Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphom...
- Suppression of spermatogenesis by bisdichloroacetyldiamines is mediated by inhibition of testicular retinoic acid biosynthesis.
- Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for Acute myelogenous leukemia (AML) in adults.
- Unusual multiple myeloma cutaneous manifestation following nonmyeloablative allogeneic stem Cell transplantation.
- Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
- Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem Cell transplantation.
- Association of multiple myeloma and inflammatory bowel Diseases.
- Overcoming immune tolerance against multiple myeloma With lentiviral calnexin-engineered dendritic cells.
- Heterogeneity of aldehyde dehydrogenase expression in lung cancer Cell lines is revealed by Aldefluor flow cytometry-based assay.
- Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde.
- Diagnosis of an early precursor-B-ALL presenting With hypereosinophilia using FISH on immunomagnetically selected CD19+ cells.
- Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem Cell transplantation in multiple myeloma.
- High-Dose Chemotherapy With Autologous Stem Cell Rescue as a Treatment Modality for Breast Cancer.
- New primary malignancy masquerading as metastatic proState adenocarcinoma.
- Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II Study.
- Flow cytometric minimal residual disease monitoring in patients With multiple myeloma undergoing autologous stem cell transplantation: a retrospective study.
- Overexpression of manganese superoxide dismutase promotes survival in Cell lines after doxorubicin treatment.
- Characterization and outcome of "hard to mobilize"'' Lymphoma patients undergoing autologous stem cell transplantation.
- Human A1 expression in Acute myeloid leukemia and its relationship to Bcl-2 expression.
- Prognostic correlation of increased angiogenesis in Acute myeloid leukemia with cytogenetics.
- Donor lymphocyte infusions for CML: possible effects of age and mobilization.
- Expression of antisense RNA to aldehyde dehydrogenase class-1 sensitizes tumor Cells to 4-hydroperoxycyclophosphamide in vitro.
- Comparison of autologous peripheral blood stem Cell dosing by ideal vs actual body weight.
- The effect of overnight storage of leukapheresis stem Cell products on Cell viability, recovery, and cost.
- Durable remission of locally advanced breast cancer With multimodality management.
- Successful salvage using mismatched umbilical cord blood transplant in an adult with recurrent Acute myelogenous leukemia failing autologous peripheral blood progenito...
- Failure of intraVenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report.
- In vitro selection for K562 cells With higher retrovirally mediated copy number of aldehyde dehydrogenase class-1 and higher resistance to 4-hydroperoxycyclophosphamide.
- Protection of hematopoietic progenitors from ultraviolet C by interleukin-1 and tumor necrosis factor-alpha.
- Human A1, a Bcl-2-related gene, is induced in leukemic Cells by cytokines as well as differentiating factors.
- Increased frequency of autoaggression Syndrome associated with autologous stem cell transplantation in breast cancer patients.
- Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide.
- Interleukin-1 and tumor necrosis factor alpha induce class 1 aldehyde dehydrogenase mRNA and protein in bone marrow Cells.
- A role for manganese superoxide dismutase in radioprotection of hematopoietic stem Cells by interleukin-1.
- Radioprotection of hematopoietic stem Cells by interleukin-1.
- Bone marrow transplantation at Shands Hospital. University of Florida.
- Cytokine protection of hematopoietic stem Cells.
- Multiorgan failure Associated with lomustine overdose.
- Role of manganese superoxide dismutase in radioprotection using gene transfer studies.
- Improved survival of patients with chronic myelogenous Leukemia undergoing allogeneic bone marrow transplantation.
- Reduced frequency of iron deficiency anaemia in sickle Cell trait.
- Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic Leukemia cells by glucocorticoids.
- Angioimmunoblastic lymphadenopathy. A case With an unusual clinical course With marked tumorous infiltration of multiple organs and striking intestinal involvement.
- [Bone marrow transplantation in Leukemia].
- Evaluation of iron status in patients on Chronic hemodialysis: relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular...
- Iron depletion and blood lead levels in a population With endemic lead poisoning.
- Lead poisoning in a West Bank Arab Village.
- [Favorable response to Metrulen in Von Willebrand''s Disease (type III)].
- Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression.
- [Interferon in immunosuppressed patients With disseminated herpes].
- Combined use of zinc protoporphyrin (ZPP), mean corpuscular volume and haemoglobin measurements for classifying microcytic RBC Disorders in children and young adults.
- Identification of community flour mills as the source of lead poisoning in West Bank Arabs.
- Is common variable hypogammaglobulinemia linked to HLA? A family study.
- Increased leucocyte alkaline phosphatase and transcobalamin III in Chronic myeloid leukaemia associated with lithium therapy.
- Digoxin-like immunoreactivity in patients with Chronic renal failure.
- Iron loading and chelation as studied in a heart Cell culture system.
- Noninvasive assessment of skin iron content in hemodialysis patients. An index of parenchymal tissue iron content?
- Factitious injury of an extremity: a Munchausen variant.
- Diagnostic value of ferritin in malignant pleural and peritoneal effusions.
- Effects of Acute iron loading on contractility and spontaneous beating rate of cultured rat myocardial cells.
- Cancer of the male breast With prolonged survival.
- The role of interleukin 3 and interleukin 6 in the protection from 4-hydroperoxycyclophosphamide and the proliferation of early human hematopoietic progenitor Cells.
- High-grade B-cell lymphoma presenting as polyserosal Disease. Diagnosis by flow cytometry.
- Protective effects of IL-1 on human hematopoietic progenitor cells treated in vitro With 4-hydroperoxycyclophosphamide.
- Role of interleukin-1 in 4-hydroperoxycyclophosphamide toxicity to bone marrow progenitor Cells: a review.
- Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with Antiphospholipid syndrome: report of two cases.
- Lead poisoning by contaminated flour.
- The effects of tumor necrosis factor-alpha on early human hematopoietic progenitor cells treated With 4-hydroperoxycyclophosphamide.
- Myelodysplastic Syndromes presenting in pregnancy. A report of five cases and the clinical outcome.
- Human N-terminal analogs of interleukin 1 beta demonstrate altered binding and function in hematopoiesis.
- Effect of IL-1 and TNF-alpha on early progenitor Cells: implications for bone marrow purging.
- All-oral chemotherapy in refractory Hodgkin''s Disease.
- Role of aldehyde dehydrogenase in the protection of hematopoietic progenitor Cells from 4-hydroperoxycyclophosphamide by interleukin 1 beta and tumor necrosis factor.
- Protection of Cells capable of reconstituting long-term bone marrow stromal cultures from 4-hydroperoxycyclophosphamide by interleukin 1 and tumor necrosis factor.
- Outcome of clinical congestive heart failure induced by anthracycline chemotherapy.
- The therapeutic potential of interleukin-1 and tumor necrosis factor on hematopoietic stem Cells.
- Reduced-intensity conditioning using fludarabine With either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT.
- Protective effects of human interleukin-1 on hematopoietic progenitor Cells from L-phenylalanine mustard.
- Genetic polymorphisms and other risk factors Associated with bisphosphonate induced osteonecrosis of the jaw.
- Treatment of refractory Acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomeras...
- Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
- Engraftment Syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival.
- Gastroparesis following bone marrow transplantation.
- Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in Lymphoma patients undergoing autologous stem cell transplantation.
- Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients With Hodgkin''s and non-Hodgkin''s Lymphoma.
- Reversal of severe graft-versus-host Disease after nonmyeloablative matched unrelated donor stem cell transplant by infusion of backup autologous peripheral blood stem...
- Morbidity and mortality following bone marrow transplantation: predictive utility of pre-BMT affective functioning, compliance, and social support stability.
Schools
Hadassah Medical School The Hebrew University Of Jerusalem
Hadassah Hospital
Shaare Zedek
University Fla
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
The Hebrew University of Jerusalem Hadassah Medical School
Hospital
-
UF Health Shands Hospital
Drug Facts
| NPI NUMBER | 1295774164 | |
| NPPES Provider LastName | MOREB | |
| NPPES Provider FirstName | JAN | |
| NPPES Provider ZIPCode | 326103003 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1452.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 174.0 | |
| Percent Opioid Claims | 11.98 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1295774164 |
| Last Name Of The Provider | MOREB |
| First Name Of The Provider | JAN |
| View All |
Similar Doctors
|
|
Dr. Ayed O. Ayed, MD |
|
Dr. Andres W. Bhatia, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Ricks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randall A. Brown, MD |
|
|
Dr. Marc S. Zumberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William L. Clapp III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia L. Close, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan B. Grosbach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine G. Simone, MD |